Source link : https://www.newshealth.biz/health-news/third-jak-inhibitor-for-alopecia-areata-wins-fda-approval/
The FDA approved the oral Janus kinase (JAK) inhibitor deuruxolitinib (Leqselvi) to treat alopecia areata, drugmaker Sun Pharmaceutical announced on Thursday. The approval stipulates use of deuruxolitinib in adults with severe alopecia areata. The JAK1/2 inhibitor is the third oral JAK inhibitor approved for alopecia areata in the past 2 years, following baricitinib (Olumiant) and […]
Author : News Health
Publish date : 2024-07-26 20:43:16
Copyright for syndicated content belongs to the linked Source.
Categories